0001702626-19-000005.txt : 20190625
0001702626-19-000005.hdr.sgml : 20190625
20190625114028
ACCESSION NUMBER: 0001702626-19-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190621
FILED AS OF DATE: 20190625
DATE AS OF CHANGE: 20190625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRAYER DAVID R
CENTRAL INDEX KEY: 0001270074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-27072
FILM NUMBER: 19917525
MAIL ADDRESS:
STREET 1: 600 MAIN STREET
STREET 2: SUITE 2
CITY: RIVERTON
STATE: NJ
ZIP: 08077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC
CENTRAL INDEX KEY: 0000946644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 520845822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
BUSINESS PHONE: 215-988-0080
MAIL ADDRESS:
STREET 1: 2117 SW HIGHWAY 484
CITY: OCALA
STATE: FL
ZIP: 32801
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-06-21
0
0000946644
HEMISPHERX BIOPHARMA INC
HEB
0001270074
STRAYER DAVID R
604 MAIN STREET
RIVERTON
NJ
08077
0
1
0
0
Chief Science/Medical Officer
Common Stock
2019-06-21
4
P
0
2481
4.03
A
5420
D
Previous Balance of the amount of Securities Owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019.
David R. Strayer
2019-06-25